MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
Status:
Completed
Trial end date:
2008-02-16
Target enrollment:
Participant gender:
Summary
The clinical study compares safety and efficacy of MK0507A (dorzolamide 1.0% / timolol 0.5%)
with 1) timolol 0.5% and with 2) concomitant therapy with dorzolamide 1.0% / timolol 0.5% in
patients with glaucoma and ocular hypertension.